VeriMomIst tipa-lauroyl sarcosinate in der Schwangerschaft sicher?
Authoritative dossiers for lauroyl/sarcosinate category members (representative: sodium N‑lauroylsarcosinate) include an OECD 414 prenatal developmental study and long‑term reproductive/2‑year studies reporting no developmental/reproductive effects at doses up to and including high NOAELs; there is no harmonised CLP reproductive classification (ECHA registration dossiers show no H360/H361). PubMed/peer‑reviewed work on lauroyl sarcosinate does not identify reproductive/teratogenic effects. (Sources: ECHA registration dossiers; OECD414 summary in registration; PubMed literature.)
Pregnancy-safe products containing tipa-lauroyl sarcosinate
Related ingredients
Frequently asked questions
- Ist tipa-lauroyl sarcosinate in der Schwangerschaft sicher?
- Authoritative dossiers for lauroyl/sarcosinate category members (representative: sodium N‑lauroylsarcosinate) include an OECD 414 prenatal developmental study and long‑term reproductive/2‑year studies reporting no developmental/reproductive effects at doses up to and including high NOAELs; there is no harmonised CLP reproductive classification (ECHA registration dossiers show no H360/H361). PubMed/peer‑reviewed work on lauroyl sarcosinate does not identify reproductive/teratogenic effects. (Sources: ECHA registration dossiers; OECD414 summary in registration; PubMed literature.)
- Ist tipa-lauroyl sarcosinate während des Stillens sicher?
- No evidence in registration dossiers or peer‑reviewed literature that lauroyl sarcosinates cause reproductive or lactation hazards or have mechanisms that would predict milk transfer or developmental toxicity. With topical cosmetic use (primarily rinse‑off surfactant), systemic exposure is expected to be negligible. (Sources: ECHA registration summaries; PubMed literature.)
- Ist tipa-lauroyl sarcosinate sicher für Babyhaut?
- The ingredient is a mild anionic surfactant used in cleansers; authoritative safety dossiers for lauroyl sarcosinates support cosmetic use and do not indicate intrinsic developmental/reproductive hazard. For baby skin (0–3 yr) increase exposure score by +1 because infant skin has an immature barrier and higher surface‑area‑to‑weight, so low but measurable dermal absorption from rinse‑off/wash products is plausible even when adult systemic exposure is negligible. There is some consumer guidance and EWG notes about nitrosamine contamination risk for this class (cosmetic formulation/contaminant concern), but not reproductive toxicity. (Sources: ECHA registration summaries; CosIng/Cosmetic ingredient listings; EWG notes.)
- Wie bewertet VeriMom tipa-lauroyl sarcosinate?
- VeriMom bewertet tipa-lauroyl sarcosinate mit 100/100 (keine bekannten Risiken) basierend auf EU CosIng, ECHA-Klassifizierungen und PubMed-Studien.
- Was sind schwangerschaftssichere Alternativen zu tipa-lauroyl sarcosinate?
- Siehe unsere kuratierte Liste der schwangerschaftssicheren Alternativen zu tipa-lauroyl sarcosinate basierend auf ähnlicher Funktion.
Prüfe jede Zutatenliste in 2 Sekunden
Lade VeriMom kostenlos — scanne jedes Produkt und sieh sofort die Schwangerschafts-Sicherheitsbewertung.
Medizinischer Haftungsausschluss
Diese Informationen dienen ausschließlich Bildungszwecken und stellen keine medizinische Beratung dar. Sicherheitsbewertungen basieren auf öffentlich zugänglichen Daten und spiegeln möglicherweise nicht alle Risiken wider. Konsultieren Sie immer Ihren Arzt, bevor Sie ein Produkt während der Schwangerschaft oder Stillzeit verwenden.